ExxPharma provides development services to pharmaceutical companies in a manner that ensures transparency, maximum quality, timely completion of deliverables and overall project success.
We follow the QbD approach to development and employ only commercially available excipients that meet IID limits, thereby de-risking long term project goals.
We provide small and large discovery companies with cost-effective and success-oriented phased product development strategy that would help them achieve their development goals in a flexible manner. Our continuous or semi-continuous manufacturing processes accommodate a wide range of clinical supply batch sizes (Phase I to III) with minimum scale up requirement.
We help virtual pharma companies realize their product development plans by providing them integrated product development services starting from preclinical studies up to the manufacturing of registration batches in an efficient and well-coordinated manner.